Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clinodevice
With
Klinar CRO
Age
40–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults of both sexes aged 40-75 years
Being diagnosed with stage II-IV chronic bronchitis-predominant COPD according to the GOLD guideline
To have quit smoking for at least 6 months
mMRC 2 and above
Receiving optimal medical treatment for COPD
Being stable for at least 3 weeks
To have completed 6 weeks of pulmonary rehabilitation before the first procedure
Having sufficient mental and physical capacity to sign the voluntary consent form for the procedure.
You may not be if
be under the age of 40 and over the age of 75
pregnant patients
breastfeeding a child
Being an active smoker
Concurrent asthma
Chronic kidney disease with GFR \<30 ml/min
Clinically significant arrhythmia, Left heart failure (EF\<45) or pulmonary hypertension (PABs\>45 mmHg)
Liver cirrhosis
Those who use anticoagulants or clopidogrel or equivalent drugs and cannot be stopped before and during the procedure, or the presence of bleeding diathesis
6 minutes walking test \<100 meters
FEV1\<15%
Those with positive early reversibility in pulmonary function tests
Patients who do not regularly take 15lgu15in therapy for COPD
Emphysema-predominant COPD patients
Presence of active malignancy
Partial CO2 pressure \> 55mmHg or pO2\<55 mmHg in room air
Active pulmonary infection
Pneumothorax or pulmonary surgery in the last 6 months
Patients with other clinically significant lung disease other than COPD
Those who have undergone a previous lung device procedure, including implanted emphysema stents, lung coil delivery, valves, lung denervation, or other devices for emphysema.
Those taking \> 10 mg of prednisolone per day
Those with a known sensitivity to the drug (such as lidocaine, 15lgu15ine and benzodiazepines) needed to perform bronchoscopy.
Clareo Health | Efficacy and Safety of Broncho Muco Cleaner Balloon Dilation Therapy
